NO20090448L - En aminoisoquinolin trombin inhibitor med forbedret biotilgjengelighet - Google Patents

En aminoisoquinolin trombin inhibitor med forbedret biotilgjengelighet

Info

Publication number
NO20090448L
NO20090448L NO20090448A NO20090448A NO20090448L NO 20090448 L NO20090448 L NO 20090448L NO 20090448 A NO20090448 A NO 20090448A NO 20090448 A NO20090448 A NO 20090448A NO 20090448 L NO20090448 L NO 20090448L
Authority
NO
Norway
Prior art keywords
aminoisoquinoline
thrombin inhibitor
improved bioavailability
compound
thrombin
Prior art date
Application number
NO20090448A
Other languages
English (en)
Norwegian (no)
Inventor
Robert Gilfillan
David Jonathan Bennett
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20090448L publication Critical patent/NO20090448L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20090448A 2006-08-08 2009-01-29 En aminoisoquinolin trombin inhibitor med forbedret biotilgjengelighet NO20090448L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06118608 2006-08-08
PCT/EP2007/058111 WO2008017650A1 (en) 2006-08-08 2007-08-06 An aminoisoquinoline thrombin inhibitor with improved bioavailability

Publications (1)

Publication Number Publication Date
NO20090448L true NO20090448L (no) 2009-02-05

Family

ID=37561257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090448A NO20090448L (no) 2006-08-08 2009-01-29 En aminoisoquinolin trombin inhibitor med forbedret biotilgjengelighet

Country Status (21)

Country Link
US (1) US8299091B2 (de)
EP (1) EP2054402B1 (de)
JP (1) JP5271904B2 (de)
KR (1) KR20090048496A (de)
CN (1) CN101511816B (de)
AR (1) AR062215A1 (de)
AU (1) AU2007283596B2 (de)
BR (1) BRPI0715384A2 (de)
CA (1) CA2659154A1 (de)
CL (1) CL2007002294A1 (de)
CO (1) CO6150148A2 (de)
IL (1) IL196783A (de)
MX (1) MX2009001384A (de)
MY (1) MY143949A (de)
NO (1) NO20090448L (de)
NZ (1) NZ574550A (de)
PE (1) PE20080526A1 (de)
RU (1) RU2437879C2 (de)
TW (1) TWI389899B (de)
WO (1) WO2008017650A1 (de)
ZA (1) ZA200900903B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150047597A (ko) * 2012-08-27 2015-05-04 어레이 바이오파마 인크. 과증식성 질환의 치료를 위한 세린/트레오닌 키나아제 억제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
GB9322976D0 (en) * 1993-11-08 1994-01-05 Pfizer Ltd Therapeutic agents
US5523308A (en) * 1995-06-07 1996-06-04 Costanzo; Michael J. Peptidyl heterocycles useful in the treatment of thrombin related disorders
NZ336046A (en) * 1996-12-06 2000-10-27 Cortech Inc Serine protease inhibitors containing substituted oxadiazole, thiadiazole and triazole peptide derivatives
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
TW575567B (en) 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
EP1303491A1 (de) * 2000-07-12 2003-04-23 Akzo Nobel N.V. Eine aminoisochinolingruppe enthaltende thrombin-hemmer

Also Published As

Publication number Publication date
CA2659154A1 (en) 2008-02-14
JP5271904B2 (ja) 2013-08-21
BRPI0715384A2 (pt) 2013-06-18
WO2008017650A1 (en) 2008-02-14
RU2009107917A (ru) 2010-09-20
AU2007283596A1 (en) 2008-02-14
IL196783A (en) 2013-03-24
AR062215A1 (es) 2008-10-22
CL2007002294A1 (es) 2008-04-18
CN101511816B (zh) 2013-01-02
ZA200900903B (en) 2010-06-30
TWI389899B (zh) 2013-03-21
KR20090048496A (ko) 2009-05-13
EP2054402A1 (de) 2009-05-06
US20100305153A1 (en) 2010-12-02
JP2010500321A (ja) 2010-01-07
PE20080526A1 (es) 2008-06-13
MX2009001384A (es) 2009-04-30
AU2007283596B2 (en) 2012-07-05
TW200821294A (en) 2008-05-16
NZ574550A (en) 2010-09-30
CO6150148A2 (es) 2010-04-20
RU2437879C2 (ru) 2011-12-27
EP2054402B1 (de) 2013-11-27
MY143949A (en) 2011-07-29
US8299091B2 (en) 2012-10-30
CN101511816A (zh) 2009-08-19
IL196783A0 (en) 2009-11-18

Similar Documents

Publication Publication Date Title
EA201100795A1 (ru) Фармацевтическая композиция эффективного ингибитора всг для перорального введения
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
RS52874B (en) THYOPHEN ANALYSIS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
WO2007135527A3 (en) Benzimidazolyl compounds
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2007087431A3 (en) Sublingual fentanyl spray
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
CL2008001005A1 (es) Compuestos derivados de azufre, inhibidores de la serina proteasa ns3 del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos asociados a la proteasa de hcv.
CL2007003540A1 (es) Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
CL2009000915A1 (es) Compuestos derivados de 1-ciano-3-pirrolidinil-bencenosulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica (copd).
WO2007011878A8 (en) Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
CL2009000914A1 (es) Compuestos derivados de 1-ciano-3-pirrolidinil-n-sustituidas-sulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica.
CL2007001597A1 (es) Compuestos derivados de 2-oxo-piridin-1(2h)-il-tiazol, imidazol o tiofen-carboxamida; composicion farmaceutica; y uso para el tratamiento de una enfermedad mediada por la estearoil-coa-desaturasa, tal como sindrome metabolico, hipertension y diabetes
BRPI0806789B8 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
WO2009030952A3 (en) Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2009145591A3 (en) Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
NO20090448L (no) En aminoisoquinolin trombin inhibitor med forbedret biotilgjengelighet
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application